|
Name
and Email Address |
Research Interests |
| * Click on the name to go to their homepage |
|
|
Training
Directors (Executive Committee) |
|
Nancy
Zahniser, PhD
Principal
Investigator
|
neuropharmacology; drug and alcohol abuse; dopamine transporter;
cocaine sensitization; ethanol and NMDA receptors; neurotransmitter
release |
|
Michael
Browning, PhD
Co-Investigator
|
LTP; protein phosphorylation; learning and memory; NMDA and
AMPA receptor; receptor trafficking; phosphatases; proteomics |
|
John
Hewitt, PhD
Co-Investigator
|
behavior genetics; twins; family studies; adolescence; substance
abuse; development; quantitative trait loci |
| |
|
| Training Preceptors |
|
Thomas
Beresford, MD
|
alcoholism; liver transplantation; brain imaging and alcohol;
HPA axis and alcohol; treatment adherence; fatty acid ethyl esters
and alcohol; cocaine abuse treatment; central pontine myelinolysis
treatment; hepatitis C and alcohol |
|
Allan
Collins, PhD
|
|
|
Thomas
Crowley, MD
|
substance dependence; human genetics; functional magnetic resonance
imaging; adolescent; conduct disorder; antisocial personality
disorder; child abuse and neglect; risk-taking; impulsivity |
|
Richard
Deitrich, PhD
|
pharmacogenetics; alcohol sensitivity; aldehyde metabolism;
alcohol metabolism |
|
Mark
Dell'Acqua, PhD
|
signal transduction; phosphorylation; protein kinases; protein
phosphatases; cAMP; calcium signaling; scaffold proteins in assembly
of localized signaling complexes; glutamatergic synapses; postsynaptic
density; NMDA and AMPA receptor localization and trafficking |
|
Robert
Freedman, MD
|
|
|
Paula
Hoffman, PhD
|
neuropharmacology; neuroadaptation; alcohol tolerance and dependence;
glutamate receptors; signal transduction; biochemical/genetic
markers of alcohol abuse/dependence |
|
Christian
Hopfer, MD
|
behavior genetics; adolescent substance abuse |
|
Lawrence
Hunter, PhD
|
bioinformatics; computational biology; computational pharmacology;
natural language processing; gene expression arrays; knowledge-based
systems |
|
Kent
Hutchison, PhD
|
|
|
Thomas
Johnson, PhD
|
genetics; QTLs; anesthesia; mice; gene mapping; bioinformatics;
microarrays; congenics |
|
David
Jones, PhD
|
alcohol; protein structure; protein-alcohol complexes; NMR spectroscopy;
x-ray crystallography |
|
Leslie
Krushel, PhD
|
translation; protein synthesis; ethanol; dendrite; neurotrophin;
IRES; RNA |
|
Sherry
Leonard, PhD
|
nicotine; nicotinic receptor; schizophrenia; mental illness;
nicotine addiction; molecular neurobiology; microarray |
|
Michael
Overduin, PhD
|
structural biology; biomolecular NMR spectroscopy; phosphoinositide
signaling; signal transduction; membrane trafficking; endocytosis |
|
Michael
Palmer, PhD
|
norepinephrine-GABA interactions; synaptic pharmacology; EtOH-GABA
interactions; EtOH-norepinephrine interactions; electrophysiology;
in vivo electrochemistry |
|
Dennis
Petersen, PhD
|
molecular mechanisms of ethanol-induced liver injury; lipid
peroxidation; proteomics |
|
Richard
Radcliffe, PhD
|
behavioral genetics; alcoholism; microarrays; mouse; alcohol
tolerance; zebrafish; mutagenesis |
|
Paula
Riggs, MD
|
comorbid disorders; adolescents; substance use disorders; integrated
treatment of comorbid psychiatric disorders and substance use
disorders |
|
James
Sikela, PhD
|
genomics; disease gene identification; human gene; genome evolution |
|
Andrew
Smolen, PhD
|
human behavioral genetics; drug abuse; alcohol abuse; attention
deficit hyperactivity disorder; candidate genes; DNA polymorphisms |
|
Michael
Stallings, PhD
|
substance use disorders; developmental psychopathology; quantitative
genetics; QTL mapping; family studies |
|
Boris
Tabakoff, PhD
|
neuroscience; molecular biology; intracellular signalling; alcohol
abuse; tolerance; humans/animals/cells; dependence; drug abuse;
transgenics; genetics |
|
Vasilis
Vasiliou, PhD
|
ethanol/acetaldehyde metabolism; aldehyde dehydrogenases; oxidative
stress; pharmacogenetics |
|
Jeanne
Wehner, PhD
|
genetics; ethanol/nicotine interactions; learning and memory |
|
Elizabeth
Whitmore, PhD
|
substance abuse; adolescents; treatment; co-occurring psychiatric
disorders; smoking cessation |
|
W.
Michael Zawada, PhD
|
alcohol; apoptosis; brain repair; differentiation; dopamine;
neurodegeneration; neuroprotection; neurotransplantation; Parkinson's
disease; stem cells |
